VolumeVol. 53 • Number No. 3 • July - September 2015 Back
Safety and Effectiveness of Insulin Lispro Mix 25/75 Among Filipino Patients with Type 1 or Type 2 Diabetes Mellitus: A Post-Marketing Surveillance Study
Authors: Mary Ann Roa, Cecille Cruz, Yun Chen, Steve C Chen, Diana M Edralin
DOI: 10.65564/pjim.4fed08f307
Date of Publication: September 2015
More Details
Authors and Affiliations:
Mary Ann Roa, M.D.*; Cecille Cruz, M.D.**; Yun Chen, M.S.***; Steve C Chen, M.D.****; Diana M Edralin, M.D.*****
*Estevez Memorial Hospital, Aquinas University Hospital, Legazpi City, Philippines
**Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of the Philippines College of Medicine, Manila, Philippines
***Lilly Suzhou Pharmaceutical Co. Ltd., Shanghai, China
****Eli Lilly and Company, Indianapolis, IN, USA;
*****Eli Lilly and Company, Pasig City, Philippines
Corresponding Author: Diana M. Edralin, M.D., Eli Lilly and Company, Unit 401-403, Tower 1, Rockwell Business Center, Ortigas Avenue, Pasig City, Philippines
Email: [email protected]
License
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0
International License, which permits use, share — copy and redistribute the material in any medium or format,
adapt — remix, transform, and build upon the material, as long as you give appropriate credit,
provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner,
but not in any way that suggests the licensor endorses you or your use. You may not use the material for
commercial purposes. If you remix, transform, or build upon the material, you must distribute your
contributions under the same license as the original. You may not apply legal terms or technological
measures that legally restrict others from doing anything the license permits. The images or other
third party material in this article are included in the article’s Creative Commons license, unless indicated
otherwise in a credit line to the material. If material is not included in the article’s Creative Commons
license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder. To view a copy of this license,
visit https://creativecommons.org/licenses/by-nc-sa/4.0/.